Cell-derived vesicles for drug therapy and diagnostics: opportunities and challenges

Area of Science:

• Biotechnology
• Cell Biology
• Nanomedicine

Background:

• Extracellular vesicles (EVs) are cell-derived nanoparticles involved in intercellular communication.
• EV cargo and composition vary with cell origin and stimulus, offering diagnostic potential.
• EVs are being investigated as natural drug delivery vehicles due to their properties.

Purpose of the Study:

• To review emerging research on extracellular vesicles for diagnostics and drug therapy.
• To discuss methods for harvesting and engineering EVs for specific applications.
• To address challenges in translating EV-based approaches to clinical use.

Main Methods:

• Literature review of recent advancements in extracellular vesicle research.
• Analysis of EV characteristics and cargo for diagnostic and therapeutic applications.
• Discussion of EV engineering techniques and preclinical considerations.

Main Results:

• EVs show promise for minimally invasive diagnosis of diseases like infections and cancers.
• Engineered EVs can be tailored for targeted drug delivery, enhancing therapeutic efficacy.
• Understanding EV properties is crucial for successful clinical translation.

Conclusions:

• Extracellular vesicles represent a promising frontier in diagnostics and drug delivery.
• Further research and development are needed to overcome challenges in clinical translation.
• EV-based strategies offer innovative solutions for personalized medicine.